186 related articles for article (PubMed ID: 23430711)
1. Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.
Pan Q; He K; Wang Y; Wang X; Ouyang W
Virus Genes; 2013 Jun; 46(3):465-72. PubMed ID: 23430711
[TBL] [Abstract][Full Text] [Related]
2. Chimeric Porcine Parvovirus VP2 Virus-like Particles with Epitopes of South African Serotype 2 Foot-and-Mouth Disease Virus Elicits Specific Humoral and Cellular Responses in Mice.
Li Q; Ma X; Shen Y; Dai J; Nian X; Shang X; Chen J; Wubshet AK; Zhang J; Zheng H
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675963
[TBL] [Abstract][Full Text] [Related]
3. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
[TBL] [Abstract][Full Text] [Related]
4. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
[TBL] [Abstract][Full Text] [Related]
6. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine.
Chen Y; Guo W; Xu Z; Yan Q; Luo Y; Shi Q; Chen D; Zhu L; Wang X
Virol J; 2011 Jun; 8():307. PubMed ID: 21679423
[TBL] [Abstract][Full Text] [Related]
7. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
8. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
[TBL] [Abstract][Full Text] [Related]
10. [Co-expression of CSFV T cell epitope E290 peptide and PPV VP2 protein in Lactobacillus casei and determination of specific antibodies in immunized mice].
Xu YG; Cui LC; Ge JW; Zhao LL; Li YJ
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):667-72. PubMed ID: 17944369
[TBL] [Abstract][Full Text] [Related]
11. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.
Pan Q; He K; Huang K
Vaccine; 2008 Apr; 26(17):2119-26. PubMed ID: 18378364
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
13. Capsid assembly is regulated by amino acid residues asparagine 47 and 48 in the VP2 protein of porcine parvovirus.
Wang J; Liu Y; Chen Y; Zhang T; Wang A; Wei Q; Liu D; Wang F; Zhang G
Vet Microbiol; 2021 Feb; 253():108974. PubMed ID: 33433338
[TBL] [Abstract][Full Text] [Related]
14. Porcine parvovirus capsid protein expressed in Escherichia coli self-assembles into virus-like particles with high immunogenicity in mice and guinea pigs.
Ji P; Liu Y; Chen Y; Wang A; Jiang D; Zhao B; Wang J; Chai S; Zhou E; Zhang G
Antiviral Res; 2017 Mar; 139():146-152. PubMed ID: 28063996
[TBL] [Abstract][Full Text] [Related]
15. [Immune Response of Recombinant Pseudorabies Virus rPRV-VP2 Expressing VP2 Gene of Porcine Parvovirus in Mice].
Fu P; Pan X; Han Q; Yang X; Zhu Q; Guo X; Zhang Y; Chen H
Bing Du Xue Bao; 2016 Mar; 32(2):195-202. PubMed ID: 27396164
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6.
Zheng HH; Wang LQ; Fu PF; Zheng LL; Chen HY; Liu F
Virol J; 2020 Feb; 17(1):19. PubMed ID: 32014014
[TBL] [Abstract][Full Text] [Related]
17. Generation of recombinant porcine parvovirus virus-like particles in Saccharomyces cerevisiae and development of virus-specific monoclonal antibodies.
Tamošiūnas PL; Petraitytė-Burneikienė R; Lasickienė R; Akatov A; Kundrotas G; Sereika V; Lelešius R; Žvirblienė A; Sasnauskas K
J Immunol Res; 2014; 2014():573531. PubMed ID: 25045718
[TBL] [Abstract][Full Text] [Related]
18. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
19. [Construction of the eukaryotic expression vector with IL-2 gene and VP2 gene of PPV and research on immunogenicity].
Cui BA; Wei ZY; Wang XB; Huang KH; Jin XX; Dong ZJ; Zheng LL
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):425-30. PubMed ID: 16755922
[TBL] [Abstract][Full Text] [Related]
20. Peptide presentation on primate erythroparvovirus 1 virus-like particles: In vitro assembly, stability and immunological properties.
Del Carmen Morán-García A; Rivera-Toledo E; Echeverría O; Vázquez-Nin G; Gómez B; Bustos-Jaimes I
Virus Res; 2016 Sep; 224():12-8. PubMed ID: 27523978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
